Transcriptomics

Dataset Information

0

Pyrazole-derived TRPC3 antagonist ameliorates synaptic dysfunctions and memory deficits in Alzheimer’s disease models


ABSTRACT: Among the canonical transient receptor potential (TRPC) channels, TRPC3 expression is uniquely upregulated in brains with Alzheimer’s disease (AD) based on our recent studies. Herein, we used JW-65, a selective inhibitor for TRPC3 over TRPC6, to investigate the potentially distinct role of TRPC3 in AD. JW-65 treatment completely restored impaired synaptic plasticity and learning memory in acute and chronic experimental AD models. JW-65 treatment of symptomatic 5XFAD transgenic mice reversed the impaired LTP, correlating with their largely corrected synaptic gene expression based on hippocampal RNA-seq data analysis. JW-65 also provided synaptic protection in primary rat hippocampal neurons against soluble β-amyloid oligomers (AβOs), primarily via restoring the AβOs-impaired Ca2+/calmodulin-mediated signaling pathways. JW-65 treatment also significantly prevented  Ca2+ overload induced by AβOs. These findings suggest that aberrantly upregulated TRPC3, as a novel non-selective ion channel, significantly contributes to Ca2+ dyshomeostasis in AD. Our work identifies TRPC3 as a potential therapeutic target for treating synaptic dysfunction of AD.

ORGANISM(S): Mus musculus

PROVIDER: GSE253510 | GEO | 2025/07/17

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-09-14 | GSE189494 | GEO
2013-09-01 | E-GEOD-49786 | biostudies-arrayexpress
2013-09-01 | GSE49786 | GEO
2024-07-17 | PXD036019 | Pride
2023-10-24 | PXD042087 | Pride
2014-07-01 | GSE38733 | GEO
2014-07-01 | E-GEOD-38733 | biostudies-arrayexpress
2017-12-30 | GSE87478 | GEO
2022-02-18 | GSE196770 | GEO
2018-12-31 | GSE110298 | GEO